Frank Moro
Internal Medicine · Peckville, PANPI 1770550766
Payments from drug & device makers
Across 441 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$4K
- Novo Nordisk$990
- GSK$791
- AstraZeneca$776
- Amarin Pharma, Inc.$492
- AbbVie$486
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$3,81037%
- Travel & lodging$1381%
- Food & beverage$6,39462%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 15 | $4,373 |
| Novo Nordisk | 83 | $990 |
| GSK | 50 | $791 |
| AstraZeneca | 47 | $776 |
| Amarin Pharma, Inc. | 45 | $492 |
| AbbVie(2 entities) | 32 | $486 |
| Pfizer | 33 | $366 |
| Kowa Pharmaceuticals America, Inc. | 20 | $294 |
| Astellas Pharma US Inc | 18 | $268 |
| Boehringer Ingelheim | 12 | $213 |
| Amgen | 9 | $140 |
| Sanofi-aventis U.S. LLC | 8 | $123 |
| Novartis | 9 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $109 |
| E.r. Squibb & Sons, L.L.C. | 8 | $105 |
| Lilly USA, LLC | 6 | $97 |
| Regeneron Healthcare Solutions, Inc. | 6 | $95 |
| Eisai Inc. | 5 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $76 |
| Abbott | 4 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Bayer | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 3 | $37 |
| Shield Therapeutics Inc | 1 | $32 |
| Mylan Specialty L.p. | 2 | $27 |
| Exact Sciences | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXLIZET$4,172
- NEXLETOL$4,172
- BREZTRI$104
- FARXIGA$104
- TRELEGY ELLIPTA$101
How this compares
$10,355 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 16 | $13,032 |
| EliquisApixaban | 55 | $12,044 |
| Atorvastatin Calcium | 173 | $2,729 |
| JanuviaSitagliptin Phosphate | 18 | $2,550 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 12 | $2,072 |
| Nebivolol Hcl | 17 | $1,512 |
| Memantine Hcl | 69 | $1,408 |
| Rosuvastatin Calcium | 45 | $1,254 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 33 | $1,240 |
| Donepezil Hcl | 75 | $1,188 |
| Amlodipine Besylate | 111 | $1,093 |
| Metoprolol Succinate | 46 | $1,065 |
| Pantoprazole Sodium | 33 | $926 |
| Montelukast Sodium | 38 | $920 |
| Ezetimibe | 21 | $692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta | $213 | $13,03216 claims |
| PfizerEliquis | $366 | $12,04455 claims |
| MerckJanuvia | $14 | $2,55018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Peckville
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.